The Executive Committee is comprised of the officers who are selected by the Board, and the Immediate Past President. It conducts the day-to-day operations on behalf of the Board during the intervals between the Board meetings.
Joris Vandeputte, DVM (Belgium): President
Jean Hugues Trouvin Pharm.D. (France) : Vice President
Philippe Sabot (France) : Executive Director
Anthony Lubiniecki, PhD (USA): Treasurer
Daniel Gaudry, DVM (France/USA): Secretary
"Ex officio" members
An ex officio member is a member of a body (a board, committee, council, etc.) who is part of it by virtue of holding another office. The “ex offcio” members of the Executive Committee are expected to participate when an agenda item relevant to their Committee is discussed. The Chairs of the Committees and the Immediate Past president are “ex officio” members:
Takao Hayakawa, PhD (Japan): Chair, Cell & Gene Therapy Committee
Rick Hill, DVM (USA) : Chair, Communication Committee
Carmen Jungbäck, DVM (Germany): Chair, Veterinary Biologicals Committee.
Timothy Schofield, M.A. (USA): Chair, Biotherapeutics Committee
Pieter Neels, MD (Belgium): Chair, Human Vaccine Committee.
John Petricciani, MD (USA): Immediate Past President
Please find all the biosketches in the Documents section